Literature DB >> 8425680

Major histocompatibility antigen-restricted cytotoxicity in inflammatory bowel disease.

K Okazaki1, M Morita, I Nishimori, S Sano, M Toyonaga, Y Nakazawa, Y Yamamoto, Y Yamamoto.   

Abstract

BACKGROUND: The role of cytotoxicity mediated by peripheral blood mononuclear cells for colonic epithelial cells in inflammatory bowel disease (IBD) is still controversial. To clarify it, we studied major histocompatibility antigen (MHC)-restricted T cell-mediated cytotoxicity (CTL).
METHODS: Cytotoxicity was measured by 51Cr release from colonic cells after the 6-hour incubation with peripheral blood mononuclear cells in 11 IBD patients (6 with Crohn's disease and 5 with ulcerative colitis).
RESULTS: CTL activity (E/T ratio = 200:1 or 100:1) for autologous target cells was significantly increased (22%-40%) in 5 of 6 CD and 4 of 5 UC patients (22%-64%) compared with that for allogeneic target cells. The increase in CTL activity was mainly inhibited by anti-MHC class I and CD8 monoclonal antibodies (50 micrograms/mL), while it was partially inhibited by anti-MHC class II or CD4 antibodies in some patients. Complement-mediated depletion of CD2+ cells also significantly decreased CTL activity.
CONCLUSIONS: The results indicate that MHC-restricted T cell cytotoxicity may play a role in mucosal damage in some patients of IBD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425680     DOI: 10.1016/0016-5085(93)90405-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Generation of MHC class I-restricted cytotoxic T cell lines and clones against colonic epithelial cells from ulcerative colitis.

Authors:  Y Yonamine; M Watanabe; F Kinjo; T Hibi
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

2.  HLA class-I-restricted and colon-specific cytotoxic T cells from lamina propria lymphocytes of patients with ulcerative colitis.

Authors:  T Sunagawa; Y Yonamine; F Kinjo; M Watanabe; T Hibi; A Saito
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

3.  Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).

Authors:  R Giacomelli; A Passacantando; I Parzanese; P Vernia; N Klidara; F Cucinelli; R Lattanzio; E Santori; P Cipriani; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

4.  Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease.

Authors:  S Müller; J Lory; N Corazza; G M Griffiths; K Z'graggen; L Mazzucchelli; A Kappeler; C Mueller
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

5.  Necrosis and apoptosis in the gastrointestinal tract.

Authors:  A J Watson
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

6.  Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon.

Authors:  S Bloom; D Simmons; D P Jewell
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 7.  Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.

Authors:  Kazuichi Okazaki; Hiroshi Nakase; Norihiko Watanabe; Yasuhiko Tabata; Yoshito Ikada; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 8.  Colitis-associated cancer: the role of T cells in tumor development.

Authors:  Maximilian J Waldner; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

9.  Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease.

Authors:  R Giacomelli; I Parzanese; G Frieri; A Passacantando; F Pizzuto; T Pimpo; P Cipriani; A Viscido; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

10.  T cell cytotoxicity of autologous and allogeneic lymphocytes in a patient with Crohn's disease.

Authors:  K Okazaki; Y Yokoyama; Y Yamamoto; M Kobayashi; K Araki; T Ogata
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.